Setting a new standard for hormone health
Alumna-founded Aavia uses education, community, and technology to change the way people think about hormones.
Differences in T cells’ functional states determine resistance to cancer therapy
Researchers decipher when and why immune cells fail to respond to immunotherapy, and suggest that T cells need a different kind of prodding in order to re-engage the immune response.
Study finds the SARS-CoV-2 virus can infect the inner ear
The prevalence of auditory symptoms in Covid-19 patients is unknown, but infection of the inner ears may be responsible for hearing and balance problems.
Exploring the human stories behind the data
Senior Brian Williams has used bioengineering as a launchpad to combat racism in public health — and he doesn’t want to stop there.
Engineers devise a way to selectively turn on RNA therapies in human cells
A new RNA-based control switch could be used to trigger production of therapeutic proteins to treat cancer or other diseases.
Carbon nanotube-based sensor can detect SARS-CoV-2 proteins
The technology could be developed as a rapid diagnostic for Covid-19 or other emerging pathogens.
At MIT, Nobel laureate Frances Arnold describes innovation by evolution
In the Hoyt C. Hottel Lecture, Arnold tells the story of her pathbreaking research to engineer better enzymes for critical applications.
Six with MIT ties elected to the National Academy of Medicine for 2021
Professors Linda Griffith and Feng Zhang along with Guillermo Ameer ScD ’99, Darrell Gaskin SM ’87, William Hahn, and Vamsi Mootha recognized for contributions to medicine, health care, and public health.
How diet affects tumors
A new study finds cutting off cells’ supplies of lipids can slow the growth of tumors in mice.
New cancer treatment may reawaken the immune system
By combining chemotherapy, tumor injury, and immunotherapy, researchers show that the immune system can be re-engaged to destroy tumors in mice.
Study shows fragile X treatment can incur resistance, suggests ways around it
While the brain acquires resistance to continuous treatment with mGluR5 inhibitor drugs, lasting effects may still arise if dosing occurs intermittently and during a developmental-critical period.
Putting artificial intelligence at the heart of health care — with help from MIT
Cardiologist Demilade Adedinsewo is using her MIT Professional Education experience to advance cardiovascular care at the Mayo Clinic.
Enabling AI-driven health advances without sacrificing patient privacy
Secure AI Labs, founded by alumna Anne Kim and MIT Professor Manolis Kellis, anonymizes data for AI researchers.
Weighing cancer cells to personalize drug choices
A new study shows a link between patient survival and changes in tumor cell mass after glioblastoma treatment.
Using AI and old reports to understand new medical images
Scientists employ an underused resource — radiology reports that accompany medical images — to improve the interpretive abilities of machine learning algorithms.